Chemoprophylaxis With Rivaroxaban for Lower Limb Deep Vein Thrombosis in Colorectal Cancer

• Status: Not yet recruiting
• Trial end date: 2024-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The chemoprophylaxis of deep vein thrombosis (DVT) with subcutaneous low-molecular-weight heparin (enoxaparin) in the postoperative period of elective surgeries is already well established in the literature and in clinical practice. However, the use of this medication can have a financial impact on the patient and the parenteral presentation itself is associated with pain at the application site, which can make it difficult for patients to adhere.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Hospital do Servidor Publico Estadual
• Treatments: Rivaroxaban

Criteria

Inclusion Criteria:

• Patients in post-operative surgery for colonic cancer.

• No contraindication for anticoagulation usage.

• Absence of renal or hepatic failure.

Exclusion Criteria:

• Pregnancy,

• age < 18 years,

• contraindication to the use of anticoagulants, -failure to complete the informed consent form. -